In this trial, we will be evaluating the safety and effect of copanlisib on survival of dogs with splenic hemangiosarcoma
inactive Mason Active hemangiosarcoma clinical trial cancer Brian Flesner
T cell therapy for drug resistant B cell Lymphoma
Mason Active lymphoma dogs canine cancer active cancer B-cell lymphoma active
NBD Peptide for Soft Tissue Sarcoma
Mason Active tumor soft tissue sarcoma sarcoma mass cancer center Cancer Care cancer active
